CROSS Research

CROSS Research is licensed for Phase I studies to be carried out in healthy volunteers and special populations with the aim of assessing drug safety, kinetics and disposition; establishing kinetic-dynamic relationships; measuring drug time-course of action, identify the proper therapeutic dose regimens and fulfil the regulatory requests. Source (opens in a new tab)

Website

https://www.croalliance.com/

Headquarters

CH

Provider types

clinical CRO